As Bristol Myers Squibb Company (BMY) Market Valuation Declined, Cullinan Associates Lowered Holding; Hartford Investment Management Co Decreased Its Harris (HRS) Position by $310,791 as Share Price Declined

Cullinan Associates Inc decreased its stake in Bristol Myers Squibb Company (BMY) by 7.18% based on its latest 2018Q3 regulatory filing with the SEC.

Lives Advice